N/A
Completed N=50
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Blood Loss
Source: ClinicalTrials.gov NCT01846195 ↗
Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Nov 2022
Primary outcomePrimary: Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw — 0; 45 participants
Summary
Non-invasive monitoring to measure changes in blood volume.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw |
0; 45 | — |
Eligibility Criteria
Inclusion Criteria
- Healthy volunteers
- Between 18-35 years of age
- Weight between 130-200 pounds
Exclusion Criteria
- Known cardiac disease
- Recent caffeine intake
- Tobacco use in the (4) hours prior to screening
- Infection
- Pregnancy
- Hemoglobin <13.5 g/dl
Data sourced from ClinicalTrials.gov (NCT01846195). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.